Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Y Yi

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Korean Journal of Internal Medicine|August 26, 1999
Protective effect of chlormethiazole, a sedative, against acetaminophen-induced liver injury in miceH C Lee, S A Jung, H K Jung, et al.
Oncology|November 5, 1999
Detection of transforming growth factor-alpha in the serum of gastric carcinoma patientsJ H Choi, H C Kim, H Y Lim, et al.
Clinical Pharmacology and Therapeutics|September 15, 2001
Ethnic differences and relationships in the oral pharmacokinetics of nifedipine and erythromycinK S Yu, J Y Cho, J H Shon, et al.
Cancer|May 15, 1997
Detection of epidermal growth factor receptor in the serum of gastric carcinoma patientsJ H Choi, J Y Oh, S K Ryu, et al.
Clinical Pharmacology and Therapeutics|April 20, 2001
Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19K S Yu, D S Yim, J Y Cho, et al.
British Journal of Cancer|July 3, 2008
ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiationH J Jun, M J Ahn, H S Kim, et al.
Journal of Clinical Pharmacology|July 7, 2000
Pharmacokinetic/pharmacodynamic evaluation of a novel potassium channel opener, SKP-450, in healthy volunteersI J Jang, K S Yu, J H Shon, et al.
British Journal of Cancer|February 26, 2009
Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patientsY H Park, M J Park, S H Ji, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Korean Journal of Internal Medicine|August 26, 1999
Protective effect of chlormethiazole, a sedative, against acetaminophen-induced liver injury in miceH C Lee, S A Jung, H K Jung, et al.
Oncology|November 5, 1999
Detection of transforming growth factor-alpha in the serum of gastric carcinoma patientsJ H Choi, H C Kim, H Y Lim, et al.
Clinical Pharmacology and Therapeutics|September 15, 2001
Ethnic differences and relationships in the oral pharmacokinetics of nifedipine and erythromycinK S Yu, J Y Cho, J H Shon, et al.
Cancer|May 15, 1997
Detection of epidermal growth factor receptor in the serum of gastric carcinoma patientsJ H Choi, J Y Oh, S K Ryu, et al.
Clinical Pharmacology and Therapeutics|April 20, 2001
Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19K S Yu, D S Yim, J Y Cho, et al.
British Journal of Cancer|July 3, 2008
ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiationH J Jun, M J Ahn, H S Kim, et al.
Journal of Clinical Pharmacology|July 7, 2000
Pharmacokinetic/pharmacodynamic evaluation of a novel potassium channel opener, SKP-450, in healthy volunteersI J Jang, K S Yu, J H Shon, et al.
British Journal of Cancer|February 26, 2009
Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patientsY H Park, M J Park, S H Ji, et al.
Pageof 4